Can pelvic lymphadenectomy be omitted in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer?
Open Access
- 5 August 2016
- journal article
- research article
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1-7
Abstract
This study aimed to identify the surgical-pathologic risk factors of lymph node metastasis (LNM) in patients with early stage squamous cell cervical cancer and to evaluate the potential efficacy of omitting pelvic lymphadenectomy. A total of 276 patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer receiving primary radical hysterectomy with pelvic lymphadenectomy were included in this study. The incidences of LNM in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer were 0 % (0/8), 17.4 % (36/207), and 29.5 % (18/61), respectively. The most common location of LNM was the obturator lymph node. Human papilloma virus 16 subtype was the most common infection in early stage squamous cell cervical cancer. Univariate analysis revealed that squamous cell carcinoma antigen (SCCAg) greater than 1.5 μg/L (p < 0.001), tumor size greater than 2 cm (p < 0.001), tumor size greater than 3 cm (p < 0.001), depth of stromal invasion (p < 0.001) and lymphovascular invasion (p < 0.001) were associated with LNM. Logistic regression analysis revealed that depth of stromal invasion {model 1 [p = 0.006; odds ratio (OR) 2.161; 95 % confidence interval (CI) 1.251–3.734], model 2 [p = 0.002; OR 2.344; 95 % CI 1.337–3.989]}, lymphovascular invasion [model 1 (p = 0.004; OR 2.967; 95 % CI 1.411–6.237), model 2 (p = 0.004; OR 2.978; 95 % CI 1.421–6.243)], and SCCAg greater than 1.5 μg/L [model 1 (p = 0.023; OR 2.431; 95 % CI 1.129–5.235), model 2 (p = 0.024; OR 2.418; 95 % CI 1.125–5.194)] were independently associated with LNM. Pelvic lymphadenectomy may be omitted in patients with SCCAg lower than 1.5 μg/L, superficial stromal invasion and without lymphovascular invasion in stage IA2, IB1, IIA1 squamous cell cervical cancer.Keywords
Funding Information
- Science and Technology Department of Guangdong province (2013B021800234)
This publication has 32 references indexed in Scilit:
- Total Laparoscopic Versus Laparotomic Radical Hysterectomy and Lymphadenectomy in Cervical CancerMedicine, 2015
- The potential for less radical surgery in women with stage IA2–IB1 cervical cancerInternational Journal of Gynecology & Obstetrics, 2015
- Microbiology of Pelvic Lymphocyst Infection after Lymphadenectomy for Malignant Gynecologic TumorsSurgical Infections, 2015
- Prevalence, Classification, and Risk Factors for Postoperative Lower Extremity Lymphedema in Women With Gynecologic MalignanciesInternational Journal of Gynecological Cancer, 2015
- Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical CancerJournal of Cancer, 2015
- Can Pelvic Lymphadenectomy be Omitted in Stage IA2 to IIB Uterine Cervical Cancer?International Journal of Gynecological Cancer, 2014
- Locoregional Spread and Survival of Stage IIA1 versus Stage IIA2 Cervical CancerAsian Pacific Journal of Cancer Prevention, 2014
- Accuracy of intraoperative pathological examination of SLN in cervical cancerGynecologic Oncology, 2013
- Squamous cell carcinoma antigen in cervical cancer and beyondJournal of Gynecologic Oncology, 2013
- Pelvic node removal and disease‐free survival in cervical cancer patients treated with radical hysterectomy and pelvic lymphadenectomyInternational Journal of Gynecology & Obstetrics, 2011